CAS 836683-15-9

Benzamide,3-[5-amino-4-(3-cyanobenzoyl)-1H-pyrazol-1-yl]-N-cyclopropyl-4-methyl-

Description:

Benzamide, 3-[5-amino-4-(3-cyanobenzoyl)-1H-pyrazol-1-yl]-N-cyclopropyl-4-methyl- is a chemical compound characterized by its complex structure, which includes a benzamide core, a pyrazole ring, and a cyclopropyl group. This compound features multiple functional groups, including an amino group and a cyanobenzoyl moiety, which contribute to its potential biological activity. The presence of the pyrazole ring suggests possible applications in medicinal chemistry, as pyrazoles are often associated with various pharmacological properties. The cyclopropyl group may enhance the compound's lipophilicity and influence its interaction with biological targets. Additionally, the compound's structure indicates potential for hydrogen bonding and π-π interactions, which are important in drug-receptor binding. Overall, this compound's unique arrangement of atoms and functional groups may make it a candidate for further research in drug development or other chemical applications. However, specific properties such as solubility, melting point, and reactivity would require empirical data for comprehensive characterization.

Formula: C₂₂H₁₉N₅O₂

Acumapimod

CAS: 836683-15-9

Formula: C₂₂H₁₉N₅O₂

Purity: %

Color and Shape: Solid

Molecular weight: 385.4186

Ref: IN-DA01EOJ9

Acumapimod

CAS: 836683-15-9

Acumapimod

Purity: ≥95%

Molecular weight: 385.42g/mol

Ref: 54-BUP03689

Acumapimod

CAS: 836683-15-9

Acumapimod (BCT-197) is an orally active inhibitor of p38α MAPK (IC50 <1 μM).

Formula: C₂₂H₁₉N₅O₂

Purity: ≥95%

Color and Shape: Solid

Molecular weight: 385.42

Ref: TM-T7367

Acumapimod

CAS: 836683-15-9

Acumapimod

Formula: C₂₂H₁₉N₅O₂

Purity: 95% (Typical Value in Batch COA)

Color and Shape: pale yellow solid

Molecular weight: 385.42g/mol

Ref: 54-BISN0274

Acumapimod

CAS: 836683-15-9

Acumapimod is an anti-inflammatory drug that has been shown to be effective in the treatment of inflammatory diseases, such as rheumatoid arthritis. It is a 2-adrenergic receptor agonist that inhibits the production of reactive oxygen species by inhibiting the enzyme xanthine oxidase. Acumapimod also has an inhibitory effect on other pro-inflammatory mediators, such as histamine, leukotrienes, and prostaglandins. Acumapimod has been shown to be effective in reducing inflammation and pain in animal models of cancer. It has also been shown to inhibit tumor growth and induce cell death in vitro. Acumapimod is used to treat inflammatory diseases because it blocks the production of reactive oxygen species, which are involved in tissue damage caused by inflammation. This drug binds with high affinity to the amide group on the 2-adrenergic receptor and inhibits the binding of ligand molecules, preventing cellular activation and

Formula: C₂₂H₁₉N₅O₂

Purity: Min. 95%

Molecular weight: 385.42 g/mol

Ref: 3D-LIB68315